Clinical Trial

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

Study acronym: EPMLARF
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic promestriene to treat symptoms of vulvovaginal atrophy of women treated for breast cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-09-05; most recent amendment 2025-04-21.
Status change: Recruiting → Active, Not Recruiting 2025-04-21
Status change: Not Yet Recruiting → Recruiting 2019-10-20
Trial Details
NCT Number NCT04081805
Lead Sponsor Federal University of São Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions Vaginal Atrophy, Vulva; Atrophy, Breast Cancer
Enrollment 195 participants
Start Date 2019-09-30
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-24